Named company: Jost Chemical Co
Dietary ingredient had a Total Aerobic Microbial Count (TAMC) above firm's specification.
Named company: Brand Packaging Group, Inc.
The inspection of your facilities revealed significant violations of the Current Good Manufacturing Practice (CGMP) regulations for Manufacturing, Packaging, Labeling, or Holding Operations for Dietary…
Named company: GOLD FOOD RESOURCES SDN BHD
"DETENTION WITHOUT PHYSICAL EXAMINATION OF PRODUCTS THAT ARE MARKETED AS FOODS, INCLUDING PRODUCTS MARKETED AS DIETARY SUPPLEMENTS, THAT CONTAIN AN ACTIVE PHARMACEUTICAL INGREDIENT". Firm/address: GOLD FOOD…
Named company: Spartan Enterprises Inc. dba Watershed Wellness Center
Based on inspectional findings and a review of your websites, we have identified serious violations of the Federal Food, Drug, and Cosmetic Act (the Act) and applicable regulations. Unapproved New/Misbranded…
Named company: Natural Solutions Foundation
Product labeled and intended to mitigate, prevent, or treat COVID-19
Named company: Herbal Vitality, Inc.
The inspection and our review of your product labeling revealed serious violations of the Federal Food, Drug, and Cosmetic Act (the Act) and FDA regulations. Unapproved New Drugs and Misbranded Drugs During…
Named company: Hekma Center Ltd.
***"DETENTION WITHOUT PHYSICAL EXAMINATION OF FOODS CONTAINING GINSENG THAT FAIL TO PROPERLY DECLARE GINSENG"***. Firm/address: Hekma Center Ltd. Date Published : 02/22/2023 1 Aara, El-masqa , Ar'Ara, Ha Zafon…
Named company: American Chinese Natural Herbs, Inc.
Based on inspectional findings, we have identified serious violations of the Federal Food, Drug, and Cosmetic Act (the Act) and applicable regulations. We have reviewed that document and our comments on your…
Named company: Organic Heirloom Plants
Based on our review, these products are unapproved new drugs sold in violation of section 505(a) of the Act, 21 U.S.C. § 355(a). Furthermore, these products are misbranded drugs under section 502 of the Act,…
Named company: Dr. Green Mom, LLC
Based on our review, these products are unapproved new drugs sold in violation of section 505(a) of the Act, 21 U.S.C. § 355(a). Furthermore, these products are misbranded drugs under section 502 of the Act,…
These results describe the included collection. Sources and coverage.